Aura Biosciences, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
AURA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
80 Guest Street, Boston, Massachusetts

Insiders trading volume in the past year

Aura Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Matrix Capital Management Company, LP 10%+ Owner $62.3M +$14M +29.1% Nov 9, 2023
Pinos Elisabet de los President and Chief Executive Officer, Director $3.48M -$276K -7.35% Feb 1, 2024
David M. Johnson Director $3.33M +$1.6M +92.8% Jun 20, 2024
Janet Jill Hopkins Chief Medical Officer $1.25M Feb 1, 2024
Julie Feder Chief Financial Officer $1.03M -$121K -10.5% Feb 1, 2024
Mark Plavsic Chief Technology Officer $982K Mar 15, 2024
Conor Kilroy General Counsel and Secretary $734K Apr 2, 2024
Medicxi Ventures Management (Jersey) Ltd 10%+ Owner $539K Nov 2, 2021
Cadmus Rich Chief Medical Officer, Head of R&D $449K Jan 19, 2023
Mark De Rosch Chief Operating Officer $448K Jan 19, 2023
Antony C. Mattessich Director $80.2K Jun 20, 2024
Sapna Srivastava Director $80.2K Jun 20, 2024
Christopher Brett Primiano Chief Business Officer $66.9K Oct 28, 2021
Giovanni Mariggi Director Oct 28, 2021
Karan S. Takhar Director Oct 28, 2021
Rajesh B. Parekh Director Jun 7, 2023

Recent Insider Transactions by Companies or Individuals for Aura Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.